Skip to main content

FBTDX

ETF
FBTDX · UNKNOWN · 82 holdings
154,51 €
▲ 2,65 € (1,75%)
Day Range
52-Week Range
Volume
Ouverture —
Moyenne 50J / 200J
Moyenne 50J / 200J

About FBTDX

No description available for this ETF.

Fund Details

Expense Ratio
Inception Date
Prev. Close
151,86 €
Exchange
UNKNOWN
Currency
USD
Holdings As Of
Apr 10, 2026
Tracked Holdings
58.5%
HHI Score
345,62
Top Sector
Healthcare (76.110063%)

Performance

Moderate (28,8%) ↘ Decelerating
1W
▲ 2,82%
1M
▲ 3,82%
3M
▲ 6,33%
6M
▲ 18,11%
YTD
▲ 5,65%
1Y
▲ 67,86%
3Y
▲ 56,98%

1M return (+3.82%) is stronger than 1W (+2.82%) — gains are slowing

Price History

Concentration Risk

50,16% Moderately Concentrated
Diversified Concentrated

The top 10 holdings represent 50,16% of the fund. This ETF is heavily concentrated — performance is largely driven by a few stocks.

Top Holdings Today

Weighted by position size
VRTX
▼ -2,34%
GILD
▼ -2,18%
AMGN
▼ -1,29%
REGN
▼ -2,47%
ASND
▼ -1,01%
ARGX
▼ -0,11%
PTCT
▼ -3,05%
Weighted avg. of top holdings ▼ -1,80%

Sector Allocation

Healthcare
76,11%

Top 10 Holdings

50,16% of fund
VRTX Vertex Pharmaceuticals, Inc.
7,99%
GILD Gilead Sciences, Inc.
7,56%
AMGN Amgen, Inc.
7,38%
REGN Regeneron Pharmaceuticals, Inc.
5,07%
ASND Ascendis Pharma A/S
4,90%
ARGX Argenx SE
4,09%
Jazz Pharmaceuticals Jazz Pharmaceuticals plc
3,92%
Merus NV Merus NV
3,21%
PTCT PTC Therapeutics, Inc.
3,10%
Benitec Biopharma, I Benitec Biopharma, Inc.
2,94%
Other positions
2,73%

All Holdings (82)

Top 10: 50,16% of fund
# Ticker Name Weight Shares Market Value
1 VRTX Vertex Pharmaceuticals, Inc. 7,99% 111 026 56,57 M
2 GILD Gilead Sciences, Inc. 7,56% 502 212 53,51 M
3 AMGN Amgen, Inc. 7,38% 179 411 52,19 M
4 REGN Regeneron Pharmaceuticals, Inc. 5,07% 59 922 35,88 M
5 ASND Ascendis Pharma A/S 4,90% 203 340 34,66 M
6 ARGX Argenx SE 4,09% 44 836 28,93 M
7 Jazz Pharmaceuticals Jazz Pharmaceuticals plc 3,92% 237 159 27,74 M
8 Merus NV Merus NV 3,21% 499 698 22,74 M
9 PTCT PTC Therapeutics, Inc. 3,10% 440 811 21,97 M
10 Benitec Biopharma, I Benitec Biopharma, Inc. 2,94% 1,53 M 20,78 M
Showing top 10 of 82 holdings · Listed: 97,27% · 2,73% in other positions

Related ETFs